| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | CA2278057C Tachykinin antagonists |
| 04/29/2004 | WO2004014943A3 Biphalin derivates and their analgesic applications |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2003053473A3 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 04/29/2004 | WO2003031623A8 Cocoa flavour precursor peptides |
| 04/29/2004 | WO2003004517A3 Peyers's patch and/or m-celle targeting ligands |
| 04/29/2004 | WO2002038796A9 Methods for determining protease cleavage site motifs |
| 04/29/2004 | WO2002018341A8 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082532 Antifungal therapeutic targets |
| 04/29/2004 | US20040082505 Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040082054 Novel depsipeptide compound |
| 04/28/2004 | EP1413583A2 Compounds that inhibit T cell proliferation and methods using the same |
| 04/28/2004 | EP1412336A1 Peptoid compounds |
| 04/28/2004 | EP1412328A1 Dolastatin 10 derivatives |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP0730469B1 Modified truncated complement system regulators |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/28/2004 | CN1492926A Preferred segments of neural thread protein and methods of using the same |
| 04/28/2004 | CN1491942A Non humidity suction stable crystalline form of N-[N-N-(4-piperidine-4-yl)-N-ethyl glycyl) compound |
| 04/28/2004 | CN1147504C New thrombin inhibitors, their preparation and use |
| 04/27/2004 | US6727366 Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors |
| 04/27/2004 | US6727282 Human immunodeficiency virus (hiv) or aids treatment |
| 04/27/2004 | US6727227 Cause an increase in superoxide dismutase activity in said subject |
| 04/27/2004 | CA2187849C Uck14 compounds |
| 04/22/2004 | WO2004033414A1 Mu opioid receptor ligands: methods of use and synthesis |
| 04/22/2004 | WO2004032827A2 Hepatitis c virus inhibitors |
| 04/22/2004 | WO2004007557A3 Tf antagonist |
| 04/22/2004 | WO2003057722A3 Cyclic tetrapeptide compound and use thereof |
| 04/22/2004 | WO2002034765A9 us0130034IDIC TRYPTASE SUBSTRATES AND ASSAY FOR TRYPTASE ACTIVITY USING SAME |
| 04/22/2004 | US20040077876 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 04/22/2004 | US20040077830 Method for synthesizing peptides comprising at least one glycine molecule |
| 04/22/2004 | US20040077627 Crystalline (N)-(2-hydroxy-3-methyl-butyryl)-1-(alaninyl)-1-amino-3-methyl-4,5,6,7 -tetrahydro-2H-3-benzazepin-2-one anhydrate; inhibiting beta-amyloid peptide release and/or synthesis |
| 04/22/2004 | US20040077620 Hypoglycemic agent |
| 04/22/2004 | US20040077612 Acting as prodrugs; higher concentration delivery of active material to target cell in hybrid form; decreasing side effects |
| 04/22/2004 | US20040077553 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 04/22/2004 | US20040077552 Inflammation-inhibiting compounds |
| 04/22/2004 | US20040077551 NS3 protease inhibitors; quinoline derivatives |
| 04/21/2004 | EP1411116A1 PEPTIDE SYNTHASE GENE, PEPTIDE SYNTHASE AND PROCESS FOR PRODUCING DIPEPTIDE |
| 04/21/2004 | EP1411063A1 Peptide nucleic acids |
| 04/21/2004 | EP1411062A1 Process for producing dipeptide,peptide synthase to be used therein and process for producing peptide synthase |
| 04/21/2004 | EP1411060A1 PROCESS FOR PRODUCING DIPEPTIDE, L−AMINO ACID AMIDE HYDROLASE TO BE USED THEREIN AND PROCESS FOR PRODUCING L−AMINO ACID AMIDE HYDROLASE |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409540A2 Melanocortin receptor ligands |
| 04/21/2004 | EP1409518A1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
| 04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 04/21/2004 | CN1146575C Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 04/20/2004 | US6723697 Antiinflammatory agents, rheumatic diseases, antiarthritic agents, inflammatory bowel disorders |
| 04/20/2004 | CA2250784C Reactor and method for solid phase peptide synthesis |
| 04/15/2004 | WO2004031216A1 Substrate for tafi (a) |
| 04/15/2004 | WO2004031215A2 Method for synthesizing peptides comprising at least one glycine molecule |
| 04/15/2004 | WO2004031154A1 Novel lactams and uses thereof |
| 04/15/2004 | WO2004030712A1 Controlled release therapeutic wound dressings |
| 04/15/2004 | WO2004030686A1 Peptides and recombinant proteins mimicking interferons |
| 04/15/2004 | WO2004003012A3 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 04/15/2004 | WO2004002509A3 Use of casein peptides for treating hypertension |
| 04/15/2004 | WO2003102579A3 Method of screening groups of radioactive molecules and applications thereof |
| 04/15/2004 | WO2003095619A3 Protein complex purification |
| 04/15/2004 | US20040073025 Thrombin inhibitors |
| 04/15/2004 | US20040072990 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072761 Heterocyclicsulfonamide hepatitis C virus inhibitors |
| 04/15/2004 | US20040072755 A fusion proteins, a binding proteins as anticarcinogenic agents for treating cancer, antiinflammatory agents, treating atherosclerosis and ischemia/ reperfusion |
| 04/15/2004 | US20040072738 Analogues of thiocoraline and be-22179 |
| 04/15/2004 | US20040072737 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents |
| 04/15/2004 | US20040072341 Bioactive oligopeptides |
| 04/14/2004 | EP1406921A1 Hypoglycaemic peptides and methods of use thereof |
| 04/14/2004 | EP1406920A1 Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities |
| 04/14/2004 | EP1406866A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/14/2004 | EP1406651A2 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 04/14/2004 | EP1406493A1 Administration of agents via the pept-2 transporter |
| 04/14/2004 | EP1210361B1 Stabilisation of freeze-dried cake |
| 04/14/2004 | EP0979240B1 Serine protease inhibitors |
| 04/14/2004 | CN1145638C Novel aspartyldipeptideamide derivatives and sweetener |
| 04/14/2004 | CN1145637C Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
| 04/14/2004 | CN1145629C Synthesis of cynnematin |
| 04/14/2004 | CN1145628C Synthesis of cynnematin |
| 04/13/2004 | US6720446 Catalyst modification to enhance neotame production |
| 04/13/2004 | US6720433 Ethylamine derivatives |
| 04/13/2004 | US6720335 Sulfonamide inhibitors of aspartyl protease |
| 04/13/2004 | US6720330 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 04/13/2004 | US6720323 Colchinol derivatives as angiogenesis inhibitors |
| 04/13/2004 | CA2322963C Methods to increase white blood cell survival after chemotherapy |
| 04/08/2004 | WO2004029034A1 Synthesis of thiophenecarboxylic acid esters for the production of ranelic acid salts |
| 04/08/2004 | WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003070690A3 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/08/2004 | WO2003018606A9 Casein derived peptides and uses thereof in therapy |
| 04/08/2004 | WO2002068601A9 Small peptides capable of modulating the function of cd66 (ceacam) family members |
| 04/08/2004 | US20040068013 Supplying in situ using amino acid; immobilization |
| 04/08/2004 | US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents |
| 04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/07/2004 | EP1405852A1 Diamine derivatives |
| 04/07/2004 | EP1404718A2 Inhibitors of memapsin 2 and use thereof |
| 04/07/2004 | EP1404704A1 Bridged bicyclic serine protease inhibitors |
| 04/07/2004 | EP1404356A2 Cd10-activated prodrug compounds |